BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 18317762)

  • 21. [Nephrotoxicity induced by chemotherapy].
    Di Vito R; Sirolli V; Amoroso L; Bonomini M
    G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L; Modha K; Albaddawi E; Subramanian S
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract]   [Full Text] [Related]  

  • 24. [Level of evidence for therapeutic drug monitoring of cisplatin].
    Hulin A; Royer B; Chatelut E; Le Guellec C;
    Therapie; 2010; 65(3):151-5. PubMed ID: 20699064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer.
    Osama H; Abdullah A; Gamal B; Emad D; Sayed D; Hussein E; Mahfouz E; Tharwat J; Sayed S; Medhat S; Bahaa T; Abdelrahim MEA
    J Am Coll Nutr; 2017 Jul; 36(5):342-346. PubMed ID: 28548561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Goren MP
    Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.
    Morgan KP; Buie LW; Savage SW
    Ann Pharmacother; 2012 Feb; 46(2):276-81. PubMed ID: 22298599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties.
    Galgamuwa R; Hardy K; Dahlstrom JE; Blackburn AC; Wium E; Rooke M; Cappello JY; Tummala P; Patel HR; Chuah A; Tian L; McMorrow L; Board PG; Theodoratos A
    J Am Soc Nephrol; 2016 Nov; 27(11):3331-3344. PubMed ID: 26961349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol.
    Maliakel DM; Kagiya TV; Nair CK
    Exp Toxicol Pathol; 2008 Sep; 60(6):521-7. PubMed ID: 18644706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)].
    Matsuoka A; Ando Y
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):200-203. PubMed ID: 28292990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
    Ruggiero A; Rizzo D; Trombatore G; Maurizi P; Riccardi R
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):19-26. PubMed ID: 26589789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New frontiers in cancer chemotherapy: cis-platinum].
    Sulkes A; Peretz T; Rizel S; Yahalom Y; Brian S
    Harefuah; 1986 Jan; 110(2):90-3. PubMed ID: 3516812
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nephrotoxicity of antineoplastic drugs].
    Suzuki T; Nosaka K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
    [No Abstract]   [Full Text] [Related]  

  • 34. The protective effect of theophyline in cisplatin nephrotoxicity.
    Mousavi SS; Zadeh MH; Shahbazian H; Khanzadeh A; Hayati F; Ghorbani A; Golzari K; Valavi E; Motemednia F; Mousavi MB
    Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):333-7. PubMed ID: 24626000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy and renal toxicity].
    Launay-Vacher V; Isnard-Bagnis C; Janus N; Karie S; Deray G
    Bull Cancer; 2008 May; 95 FMC Onco():F96-103. PubMed ID: 18511375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.
    Marijic VF; Makarevic J; Stojkovic R; Kalinic L; Katalenic D; Radacic M
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):675-80. PubMed ID: 19229375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
    Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
    Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice.
    Nitha B; Janardhanan KK
    Food Chem Toxicol; 2008 Sep; 46(9):3193-9. PubMed ID: 18692113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticancer drug-induced nephrotoxicity].
    Isnard-Bagnis C; Moulin B; Launay-Vacher V; Izzedine H; Tostivint I; Deray G
    Nephrol Ther; 2005 May; 1(2):101-14. PubMed ID: 16895673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotoxicity--what do we know and what don't we know?
    Skinner R
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):128-34. PubMed ID: 21285904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.